Our job is to make sure that you know the right questions to ask your clinician and then make an informed choice
However, some potential risks include: Injection Site Discomfort: Bruising, swelling, or redness at the IV or IM injection site
Esta observacin, aunque alentadora, debe interpretarse con prudencia: la ausencia de evidencia de efectos secundarios no es una prueba de ausencia
These medications help manage diabetes and weight loss, making it crucial for healthcare providers to know the difference between expected drug effects and actual medical conditions
Common signs of NAION include: Sudden, unilateral painless loss of vision Visual field defect (usually altitudinal) Blurred vision Dyschromatopsia (new onset impairment or loss of color vision) Relative afferent pupillary defect Optic disc swelling with or without hemorrhages A patient starting a GLP-1RAespecially if they have diabetes or age-related macular degeneration should have an in-person, comprehensive, dilated eye examination either within the 12 months prior to starting therapy or a baseline examination within one month of initiating therapy
